Application of chimeric antigen receptor-T cell therapy in hematological diseases: reports from the 57th American Society of Hematology annual meeting / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 4-6, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-485888
ABSTRACT
Chimeric antigen receptor-T cell (CAR-T) therapy is one of the effective novel immunotherapy for malignancies, and it has a great effect on leukemia and lymphoma. More researches are needed to improve the understanding of CAR-T therapy and promote the development of this technology in order to treat hematological malignancies from a novel perspective.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS